VRTX
Vertex Pharmaceuticals Incorporated
NMS
$422.36
-2.73
(-0.64%)
Pullback · -1.23σ
Valuation
Market cap
$107.2B
P/E (ttm)
25.1
Forward P/E
19.7
Beta (5y)
0.30
Shares out
253.8M
Div yield
—
Profitability & returns
ROE
24.2%
Net margin
35.5%
FCF margin
22.8%
Debt / equity
0.10
Trading information
Last price
$422.36
Day range
$422.36 – $422.36
52-wk range
$412.27 – $507.92
Avg volume
1.3M
RSI (2)
6.0
TAO zone
Pullback
Company
Sector
Healthcare
Industry
Biotechnology
Exchange
NMS
Next earnings
2026-08-03
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F…